As CCL2 upregulation in obesity promotes macrophage recruitment into adipose tissue [142, 163, 164], inhibitors of CCL2 have been developed to reduce TAM within the tumor microenvironment and at sites of metastasis. The gene discussed is CCL2; the disease is obesity due to melanocortin 4 receptor deficiency.